Literature DB >> 23489869

Prostate radiotherapy for men with metastatic disease: a new comparison in the STAMPEDE trial.

C C Parker, M R Sydes, M D Mason, N W Clarke, D Aebersold, J S de Bono, D P Dearnaley, A W S Ritchie, J M Russell, G Thalmann, M K B Parmar, N D James.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23489869     DOI： 10.1016/j.clon.2013.01.005

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN： 0936-6555            Impact factor:   4.126


× No keyword cloud information.
  5 in total

1.  Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.

Authors:  Chris C Parker; Nicholas D James; Christopher D Brawley; Noel W Clarke; Adnan Ali; Claire L Amos; Gerhardt Attard; Simon Chowdhury; Adrian Cook; William Cross; David P Dearnaley; Hassan Douis; Duncan C Gilbert; Clare Gilson; Silke Gillessen; Alex Hoyle; Rob J Jones; Ruth E Langley; Zafar I Malik; Malcolm D Mason; David Matheson; Robin Millman; Mary Rauchenberger; Hannah Rush; J Martin Russell; Hannah Sweeney; Amit Bahl; Alison Birtle; Lisa Capaldi; Omar Din; Daniel Ford; Joanna Gale; Ann Henry; Peter Hoskin; Mohammed Kagzi; Anna Lydon; Joe M O'Sullivan; Sangeeta A Paisey; Omi Parikh; Delia Pudney; Vijay Ramani; Peter Robson; Narayanan Nair Srihari; Jacob Tanguay; Mahesh K B Parmar; Matthew R Sydes
Journal:  PLoS Med       Date:  2022-06-07       Impact factor: 11.613

2.  This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.

Authors:  Francesca Schiavone; Riya Bathia; Krishna Letchemanan; Lindsey Masters; Claire Amos; Anna Bara; Louise Brown; Clare Gilson; Cheryl Pugh; Nafisah Atako; Fleur Hudson; Mahesh Parmar; Ruth Langley; Richard S Kaplan; Chris Parker; Gert Attard; Noel W Clarke; Silke Gillessen; Nicholas D James; Tim Maughan; Matthew R Sydes
Journal:  Trials       Date:  2019-05-29       Impact factor: 2.279

3.  A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP).

Authors:  Patrick P J Phillips; Kelly E Dooley; Stephen H Gillespie; Norbert Heinrich; Jason E Stout; Payam Nahid; Andreas H Diacon; Rob E Aarnoutse; Gibson S Kibiki; Martin J Boeree; Michael Hoelscher
Journal:  BMC Med       Date:  2016-03-23       Impact factor: 8.775

4.  Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer: Data From Patients in the Control Arm of the STAMPEDE Trial.

Authors:  Nicholas D James; Melissa R Spears; Noel W Clarke; David P Dearnaley; Malcolm D Mason; Christopher C Parker; Alastair W S Ritchie; J Martin Russell; Francesca Schiavone; Gerhardt Attard; Johann S de Bono; Alison Birtle; Daniel S Engeler; Tony Elliott; David Matheson; Joe O'Sullivan; Delia Pudney; Narayanan Srihari; Jan Wallace; Jim Barber; Isabel Syndikus; Mahesh K B Parmar; Matthew R Sydes
Journal:  JAMA Oncol       Date:  2016-03       Impact factor: 31.777

5.  Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.

Authors:  Christopher C Parker; Nicholas D James; Christopher D Brawley; Noel W Clarke; Alex P Hoyle; Adnan Ali; Alastair W S Ritchie; Gerhardt Attard; Simon Chowdhury; William Cross; David P Dearnaley; Silke Gillessen; Clare Gilson; Robert J Jones; Ruth E Langley; Zafar I Malik; Malcolm D Mason; David Matheson; Robin Millman; J Martin Russell; George N Thalmann; Claire L Amos; Roberto Alonzi; Amit Bahl; Alison Birtle; Omar Din; Hassan Douis; Chinnamani Eswar; Joanna Gale; Melissa R Gannon; Sai Jonnada; Sara Khaksar; Jason F Lester; Joe M O'Sullivan; Omi A Parikh; Ian D Pedley; Delia M Pudney; Denise J Sheehan; Narayanan Nair Srihari; Anna T H Tran; Mahesh K B Parmar; Matthew R Sydes
Journal:  Lancet       Date:  2018-10-21       Impact factor: 79.321
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.